[1]
2023. Early Insights into the Characteristics of Tralokinumab Patients in a Real-World Setting in the United States. SKIN The Journal of Cutaneous Medicine. 7, 3 (May 2023), s205. DOI:https://doi.org/10.25251/skin.7.supp.205.